These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23236680)

  • 1. Activated glycyrrhizinic acid: significance against viral infections.
    Kukurtchu B
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():46-7. PubMed ID: 23236680
    [No Abstract]   [Full Text] [Related]  

  • 2. [GLYCYRRHIZINIC ACID--AN ALTERNATIVE METHOD FOR TREATMENT OF CONDYLOMATA ACUMINATA].
    Kolev N; Bakardzhiev I; Kovachev E; Ivanov S
    Akush Ginekol (Sofiia); 2015; 54(9):16-8. PubMed ID: 26863790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycyrrhizin increases survival of mice with herpes simplex encephalitis.
    Sekizawa T; Yanagi K; Itoyama Y
    Acta Virol; 2001 Feb; 45(1):51-4. PubMed ID: 11394578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical foscarnet for aciclovir-resistant mucocutaneous herpes infections in AIDS.
    Smith NA; Wood C; Asboe D; Bingham JS
    AIDS; 1997 Feb; 11(2):254-5. PubMed ID: 9030377
    [No Abstract]   [Full Text] [Related]  

  • 5. Resiquimod 3M.
    Jones T
    Curr Opin Investig Drugs; 2003 Feb; 4(2):214-8. PubMed ID: 12669385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients.
    Kim JH; Schaenman JM; Ho DY; Brown JM
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):259-64. PubMed ID: 20615475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Herpes diseases in pregnant patients and newborn infants. Prognosis and therapy of intrauterine and neonatal herpes simplex virus diseases].
    Peuckert W
    Klin Padiatr; 1988; 200(6):471-3. PubMed ID: 2853248
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 9. Marine organisms as a therapeutic source against herpes simplex virus infection.
    Vo TS; Ngo DH; Ta QV; Kim SK
    Eur J Pharm Sci; 2011 Sep; 44(1-2):11-20. PubMed ID: 21782018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of 0-beta-D-arabinofuranosyladenine. IV. Activity against intracerebral herpes simplex virus infections in mice.
    Sloan BJ; Miller FA; Ehrlich J; McLean IW; Machamer HE
    Antimicrob Agents Chemother (Bethesda); 1968; 8():161-71. PubMed ID: 4309848
    [No Abstract]   [Full Text] [Related]  

  • 11. [Course and treatment of herpervirus hominis infections. II. Therapy].
    Luger A
    Z Haut Geschlechtskr; 1971 Jul; 46(13):399-408. PubMed ID: 4331019
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of desoxyribonuclease on herpes simplex virus].
    Kossak NI
    Mikrobiol Zh; 1967; 29(4):312-6. PubMed ID: 4310245
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical aspects and therapy of infections with herpes simplex viruses].
    Schneweis KE; Eis-Hübinger AM
    Internist (Berl); 1992 Sep; 33(9):581-5. PubMed ID: 1328106
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of therapeutic drug monitoring in the long-term valaciclovir therapy of relapsing herpes simplex virus encephalitis in children.
    Lim M; Menson E; Tong CY; Lin JP
    J Antimicrob Chemother; 2009 Dec; 64(6):1340-1. PubMed ID: 19828489
    [No Abstract]   [Full Text] [Related]  

  • 15. Antivirals for herpes simplex viruses.
    Sawleshwarkar S; Dwyer DE
    BMJ; 2015 Jul; 351():h3350. PubMed ID: 26160487
    [No Abstract]   [Full Text] [Related]  

  • 16. [Herpetic eye disease caused by herpes simplex virus].
    Ben-Simon G; Bareguet I
    Harefuah; 2001 Oct; 140(10):959-66. PubMed ID: 11681133
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological effects of coordinated compounds of transitional metals. 7. Antiviral activity of 4-methyl-2-aminopyridine palladium chloride against herpes simplex virus type 1 and type 2 in vitro and in vivo].
    Wutzler P; Thiel KD; Tonew M; Tonew E; Schröer HP; Stelzner A
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Oct; 266(3-4):563-6. PubMed ID: 2830739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
    de Clercq E
    Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935
    [No Abstract]   [Full Text] [Related]  

  • 19. New anti-HSV therapeutics target the helicase-primase complex.
    Crumpacker CS; Schaffer PA
    Nat Med; 2002 Apr; 8(4):327-8. PubMed ID: 11927930
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
    Tolo FM; Rukunga GM; Muli FW; Njagi EN; Njue W; Kumon K; Mungai GM; Muthaura CN; Muli JM; Keter LK; Oishi E; Kofi-Tsekpo MW
    J Ethnopharmacol; 2006 Mar; 104(1-2):92-9. PubMed ID: 16198524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.